Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Sign-on Letter Supporting Draft Legislation Addressing Budget Neutrality Impact to Physician Payment Rates
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Request to FDA to Extend Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Comments on CY 2024 Physician Fee Schedule Proposed Rule
-
Stakeholder Letter Calling for Physician Payment Legislation Based on MEI
-
Sign-on Letter Opposing Updated VALID Act & ACM Exemption
-
Sign-on Letter Asking Congress to Address Instability of the Medicare Physician Payment System
-
Sign-on Letter to Congressional Leadership Concerning the VALID Act
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
ACMG Response to Opposing Inclusion of the VALID Act in the FDASLA Act